Tracy Tomlinson, 58, is the first person to receive the ZI-MA4-1 therapy as part of a clinical trial for advanced cancers. Unlike bespoke treatments, this 'off-the-shelf' method uses donor immune cells, potentially making advanced cell therapy more accessible and affordable for future patients.